A yearlong pattern of intense disruption followed by little improvement played out across nearly every major healthcare ...
French pharmaceutical group Sanofi said on Monday the U.S. Food and Drug Administration's decision on its investigative drug ...
Ascendis Pharma's Yorvipath and Skytrofa drove Q3 revenues to €213.6 million, nearly quadrupling year-over-year. Read why ...
A U.S. regulatory decision on tolebrutinib will again be delayed while a late-stage trial of the drug for a different form of ...
In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...
The FDA encourages consumers to report any adverse reactions through its MedWatch reporting system. A nasal spray sold ...
Doctors and dietitians explain how energy drinks affect your body, how much caffeine is safe, and why sugar and sweeteners ...
Pro-life groups are holding the U.S. Food and Drug Administration and its commissioner Marty Makary accountable for leaving ...
The Philadelphia Phillies’ superstar might have risked "neurological complications” with an unapproved health procedure.
A total of 1,021 cases of the frozen original White Castle burgers — often found in your local grocery store or convenience ...
Trump's decision to move marijuana to Schedule III could ease taxes and expand medical access, but industry leaders warn it ...
The following is the transcript of the interview with Sen. Bill Cassidy, Republican of Louisiana, tthat aired on "Face the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results